Skip to Main Content
Try STAT+ TODAY
Trending:
Health
STAT+
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Adam's Take
STAT+

A deeply troubled drug company fires its CEO, who then unfires himself. Comedy, chaos ensue

  • Adam Feuerstein

By Adam Feuerstein May 23, 2018

Reprints

Let’s recap the last 12 hours at Rockwell Medical (RMTI) when crazytown came to visit.

On Tuesday night, the drug maker’s board of directors fired CEO Robert Chioini. Then, as the sun rose on Wednesday morning, Chioini unfired himself, alleging board members may have violated federal securities laws.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

Live blog: Tracking the meeting of the FDA advisory…
Live blog: Tracking the meeting of the FDA advisory panel on Covid vaccines
Watch: How do the new obesity drugs work?
Watch: How do the new obesity drugs work?
Study of pancreatitis surgery patients finds steady decline in…
Study of pancreatitis surgery patients finds steady decline in survival and need for better addiction support
A bellwether for biosimilars: Why the new competition for…
A bellwether for biosimilars: Why the new competition for Humira matters to pharma, payers, and patients
HHS’ Becerra on enrolling in Medicare, annual Covid vaccines,…
HHS’ Becerra on enrolling in Medicare, annual Covid vaccines, and seniors’ mental health
Warren urges the FTC to scrutinize two pharma mergers…
Warren urges the FTC to scrutinize two pharma mergers over “anti-competitive” practices

Recommended Stories